SLC5A4 and cancer: Effectively mapping the regulation of these sodium transporters in cancer could have significant clinical implications, as early studies examining the effects of VGSC or Na,K-ATPase-blocking drugs in cancer patients have, thus far, proved inconclusive [22,23,24,25].